Challenging the "Noble" dual heroes! The CEO of Pfizer (PFE.US) vows to go "All in" on weight loss drugs.
Pfizer is fully committed to developing its experimental weight loss drug and has been recruiting more experts in the field.
Top Gap Ups and Downs on Monday: DELL, RACE, CVS and More
Obesity Drug Developer Metsera Files for $100M IPO
Dividend Aristocrats Can't Handle Rising Rates. These Are Better Income Bets. -- Barrons.com
Goldman Sachs Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating, Announces Target Price $124
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
Mimo803734 : it was even 2% down in Europe before early trading started....very peculiar